| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/16/2006 | US7045541 Compounds for the treatment of metabolic disorders |
| 05/16/2006 | US7045534 Methods of reducing angiogenesis |
| 05/16/2006 | US7045528 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 05/16/2006 | US7045524 Bactericides; infection therapy; topical administering |
| 05/16/2006 | US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field |
| 05/16/2006 | US7045520 Opioid receptor active compounds |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045148 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 05/16/2006 | US7045095 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/11/2006 | WO2006050045A2 Inhibitors of jun n-terminal kinases for treating glaucomatous retinopathy and ocular diseases |
| 05/11/2006 | WO2006049250A1 Aqueous eye drops with accelerated intraocular migration |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | US20060100283 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 05/11/2006 | US20060100281 Method of treating tinnitus |
| 05/11/2006 | US20060100269 Use of 10-aminoaliphatyl-dibenz[b,f]oxepines for the treatment of degenerative ocular disorders |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100141 Administering peptidic or peptidomimetic compound having segment competent for importation of molecule into mast cells, and asecond segment for having an anti-allergic effect within mast cells for reducing late phase inflammatory responses induced by mitogen activated protein kinase activation |
| 05/11/2006 | US20060099672 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types for example |
| 05/11/2006 | US20060099215 Walnut and ryegrass allergens |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2560559A1 Aqueous intraocular penetration-promoting eye drop |
| 05/10/2006 | EP1655990A1 Wireless microphone communication system |
| 05/10/2006 | EP1653974A1 Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application |
| 05/10/2006 | EP1653968A2 Method for modulating calcium ion-release-activated calcium ion channels |
| 05/10/2006 | EP1581047A4 Radiopaque animal chew |
| 05/10/2006 | EP1418911B1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 05/10/2006 | EP1370553B1 Rho-kinase inhibitors |
| 05/10/2006 | EP1307189B1 Use of hydroxyethylrutosides for treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 05/10/2006 | EP1294874B1 Cd154 variants and uses thereof |
| 05/10/2006 | EP1194525B1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | CN1771039A Use of the sgk gene family for diagnosis and therapy of cataracts and glaucoma |
| 05/10/2006 | CN1768802A Chinese medicine for treating ocular funcus hemorrhage caused by yin deficiency, liver sthenia, heat impairing collaterals and preparation method |
| 05/10/2006 | CN1768797A Chinese medicine for treating star-like cataract caused by viral keratitis and preparation method thereof |
| 05/10/2006 | CN1768773A Eye drop for decomposing denatured protein and eliminating cataract and preparation process thereof |
| 05/10/2006 | CN1768756A Application of a kind of alpha glycosidase inhibitor in preparation of medicine to prevent or treat diabetic microvascular complication |
| 05/10/2006 | CN1768749A Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 05/10/2006 | CN1768735A Medicaments for diabetic complication and neuropathy, and uses thereof |
| 05/10/2006 | CN1255552C Method for using human CRYGS gene and its coded products to diagnose and treat lesion of crystalline lens |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255411C Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments |
| 05/10/2006 | CN1255407C Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines |
| 05/10/2006 | CN1255401C Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/10/2006 | CN1255391C COLCHINOL derivatives as vascular damaging agents |
| 05/10/2006 | CN1255178C Externally used traditional Chinese medicine preparation for treating teenager myopia and its preparing method |
| 05/10/2006 | CN1255049C Functional agent for decomposing nicotine and method of preparing the same |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041662 Substituted benzo [b] azepin-2-one compounds |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/09/2006 | US7041063 Noninvasive measurement of chemical substances |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2257646C Benzo[g]quinoline derivatives |
| 05/09/2006 | CA2257328C Thiazole derivatives |
| 05/04/2006 | WO2006046584A1 Remedy for visual cell injuries |
| 05/04/2006 | WO2006046583A1 Material for regenerating visual cells or functions thereof |
| 05/04/2006 | WO2006046557A1 Abnormal protein removing composition |
| 05/04/2006 | WO2006046492A1 Novel ppar regulating agent and method of screening the same |
| 05/04/2006 | US20060094879 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 05/04/2006 | US20060094775 Remedy for corneal ulcer |
| 05/04/2006 | US20060094746 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-hydroxythieno[2,3-c]isoquin-5(4H)-one, used for treating tumor diseases, leukaemia, sarcoma, tissue damage due to ischemia and reperfusion, inflammatory disease, retinal ischemia or brain trauma |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094688 Histamine release inhibitor |
| 05/04/2006 | US20060094677 Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics |
| 05/04/2006 | US20060093626 Lyophilization; conjugated Streptococcus pneumoniae capsular polysaccharide serotype is adjuvanted with 3-0 deacylated monophosphoryl lipid A (3D-MPL) and devoid of aluminium-based adjuvant |
| 05/04/2006 | US20060093612 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/04/2006 | DE19954788B4 Neue pharmazeutische Verwendung von Mibefradil in der chirurgischen Ophthalmologie New pharmaceutical use of mibefradil in surgical ophthalmology |
| 05/03/2006 | EP1652539A1 Method of manufacturing a stent comprising an anti-angiogenic composition |
| 05/03/2006 | EP1651232A2 Compounds for inflammation and immune-related uses |
| 05/03/2006 | EP1651210A1 Dispersible formulation of an anti-inflammatory agent |
| 05/03/2006 | EP1515955A4 Chemical process |
| 05/03/2006 | EP1513836B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 05/03/2006 | EP1501530A4 Prostaglandin f2 alpha analogs in combination with antimicrobial for treating glaucoma |
| 05/03/2006 | EP1499606B1 3, 4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists |
| 05/03/2006 | EP1389129A4 Methods of treating respiratory conditions |
| 05/03/2006 | EP1312380B1 Aseptics |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1074542B1 Sulfonamide-containing indole compounds |
| 05/03/2006 | EP0937069B1 Piperazino derivatives as neurokinin antagonists |
| 05/03/2006 | CN1767870A Otorhinological delivery device |
| 05/03/2006 | CN1767839A Antiallergic composition |
| 05/03/2006 | CN1765404A Chinese medicinal formulation for nourishing liver and improving eyesight and its preparation method |
| 05/03/2006 | CN1765354A Three dimensional eye patch for treating eye wrinkles an its preparation method |
| 05/03/2006 | CN1254250C Chinese medicine for treating eye diseases and its preparation process |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7037928 Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037533 Functional agent for decomposing nicotine and method of preparing the same |
| 05/02/2006 | CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 05/02/2006 | CA2326804C Compounds with activity on muscarinic receptors |
| 05/02/2006 | CA2173974C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 04/27/2006 | WO2006045050A1 Methods and compositions for protecting cells from ultrasound-mediated cytolysis |
| 04/27/2006 | WO2006044412A1 Novel b1 bradykinin receptor antagonists |
| 04/27/2006 | WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |